"Nice editorial voice. Felt human."
The Chemicals & Pharma Outlook 2027: Science, Manufacturing and Markets in Transition
Chemicals and pharmaceuticals enter 2027 amid continuing changes in science, manufacturing, supply chains, sustainability and technology. Specialty materials are enabling new applications, pharmaceutical production is becoming increasingly sophisticated and biotechnology is expanding the possibilities of industrial and medical innovation. This edition examines the landscape at the beginning of the year across chemicals and pharma, connecting scientific developments with the manufacturing capabilities, regulatory environment and market forces influencing how the industry evolves.
Editor's Note
The chemicals and pharmaceutical industries are shaped simultaneously by science, manufacturing capability and changing market requirements. As 2027 begins, developments across these areas are creating both opportunities and new operational challenges. This edition examines the forces influencing the sector and provides a broad view of how chemistry, pharmaceuticals, biotechnology and materials are progressing through a period of significant transition.
What Readers Say
"Clean writing and good flow between articles."
"Well-rounded summary of the year."
"Good insights for business and plant leaders."
"Very engaging and nicely paced."
"Thought-provoking without being heavy."
